MidWestOne Financial Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$225K Sell
2,636
-1,194
-31% -$98K 0.03% 288
2025
Q3
$298K Sell
3,830
-96
-2% -$7.5K 0.04% 251
2025
Q2
$307K Sell
3,926
-150
-4% -$11.2K 0.04% 247
2025
Q1
$295K Buy
4,076
+150
+4% +$10.7K 0.04% 231
2024
Q4
$291K Sell
3,926
-1,125
-22% -$78.7K 0.04% 245
2024
Q3
$333K Sell
5,051
-15
-0.3% -$1.09K 0.05% 236
2024
Q2
$468K Buy
5,066
+15
+0.3% +$1.33K 0.08% 209
2024
Q1
$483K Hold
5,051
0.09% 211
2023
Q4
$385K Buy
5,051
+96
+2% +$6.68K 0.07% 220
2023
Q3
$343K Sell
4,955
-1,212
-20% -$97.4K 0.08% 215
2023
Q2
$582K Buy
6,167
+2,337
+61% +$203K 0.13% 190
2023
Q1
$317K Buy
+3,830
New +$301K 0.07% 212
2022
Q3
Sell
-2,337
Closed -$222K 231
2022
Q2
$222K Buy
+2,337
New +$242K 0.05% 213
2021
Q4
Sell
-3,240
Closed -$367K 247
2021
Q3
$367K Buy
+3,240
New +$370K 0.09% 178
2020
Q2
Sell
-4,791
Closed -$301K 146
2020
Q1
$301K Sell
4,791
-426
-8% -$30.7K 0.11% 152
2019
Q4
$405K Sell
5,217
-1,704
-25% -$133K 0.08% 170
2019
Q3
$506K Sell
6,921
-15,441
-69% -$1.08M 0.16% 140
2019
Q2
$1.38M Buy
+22,362
New +$1.35M 0.38% 58

Other funds holding EW

MidWestOne Financial Group's EW Position: Q4 2025 in Review

MidWestOne Financial Group reduced its Edwards Lifesciences (EW) stake by 31% in Q4 2025, selling an estimated $98K and leaving 2,636 shares worth $225K. The position accounts for 0.03% of the portfolio, ranked #288.

MidWestOne Financial Group first reported a position in EW in Q2 2019 and has held it in 18 quarters since. The position peaked at $1.38M in Q2 2019. 1,314 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • MidWestOne Financial Group held 2,636 shares of Edwards Lifesciences worth $225K as of Q4 2025.
  • MidWestOne Financial Group sold 1,194 Edwards Lifesciences shares in Q4 2025, an estimated $98K.
  • Edwards Lifesciences made up 0.03% of MidWestOne Financial Group's portfolio in Q4 2025, its #288 holding.
  • MidWestOne Financial Group first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 18 quarters since.
  • MidWestOne Financial Group's Edwards Lifesciences position peaked at $1.38M in Q2 2019.
  • 1,314 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.